1Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 2Center for Human Immunobiology, Department of Medicine, Feinberg ...
Cancer Biology Evolution Program, Integrated Mathematic Oncology Department, Radiology Department, Moffitt Cancer Center, Tampa, Florida. *Corresponding Author: Robert A. Gatenby, Cancer Biology ...
Search for other works by this author on: ...
1Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Freiburg University Medical Center, Freiburg, Germany.
Cancer Res (2025) 85 (8_Supplement_2): LB091.
AbstractSignificance:. Brimstalt Therapeutics is developing a small molecule drug for treatment of cancer patients with tumors that express the tumor associated enzyme (TAE), SULT1A1. The lead ...
Abstract. Platinum-resistant ovarian cancer remains one of the greatest challenges in oncology, with limited treatment options and poor survival outcomes. To address this unmet need we develop MDC-735 ...
University of Minnesota, Minneapolis, MN.
Cellentia Inc., Foster City, CA. Search for other works by this author on: ...
MS Bioworks, LLC, Ann Arbor, MI.
1Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. 2Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer ...
1Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results